Aurora Cannabis (ACB) Preferred Stock Liabilities (2018)
Aurora Cannabis (ACB) posted quarterly Preferred Stock Liabilities of $298.2 million for Q4 2018, up 75.09% on a QoQ basis from $170.3 million in Q2 2018.
Aurora Cannabis (ACB) Preferred Stock Liabilities (2018) Analysis & Trends
Aurora Cannabis (ACB) has reported Preferred Stock Liabilities for 1 consecutive years, with $298.2 million the latest figure, recorded in Q4 2018.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $298.2 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $298.2 million (changed N/A YoY) and the FY2018 annual result came in at $170.3 million, changed N/A from the prior year.
- Preferred Stock Liabilities grew to $298.2 million in Q4 2018 per ACB's latest filing, from $170.3 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for ACB reached as high as $298.2 million in Q4 2018 and fell as low as $170.3 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 298.18 Mn |
| Jun 30, 2018 | 170.30 Mn |